Abacavir CAS 136470-78-5 Intende 99.0%~ 101.0% API Factory anti-HIV
Manufacturer Supple cum High puritate et stabulo Quality
Chemical Name: Abacavir
CAS: 136470-78-5
Validum nucleoside analogum transversum transcriptase inhibitor (NRTI) tractabant HIV et AIDS.
API High Quality, Commercial Production
Nomen chemicum | Abacavir |
CAS Number | 136470-78-5 |
CATTUS Number | RF-API62 |
Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
Formulae hypotheticae | C14H18N6O |
M. Pondus | 286.33 |
Liquescens punctum | 165℃ |
Shipping Condition | Sub Ambient Temperature |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad Off-White Crystalline pulveris |
Lepidium sativum | (1) IR (2) HPLC (3) Sulfate |
Aqua | ≤0.50% |
Residere in Ingnition | ≤0.20% |
Terminus Abacavir Enantiomer | ≤0.20% |
I) Substantiae Related | |
Descyclopropyl Abacavir | ≤0.20% |
Trans-Abacavir | ≤0.20% |
O-Pyrimidinyl Abacavir | ≤0.20% |
t-Butyl Derivate Abacavir | ≤0.20% |
Quis non specificatus immunditia | ≤0.10% |
Totalis immunditias | ≤0.80% |
2) Enantiomeric Puritas | Abacavir Enantiomer ≤0.20% |
III) Residua Solvents | |
Methanol | ≤0.30% |
Acetone | ≤0.50% |
Ethanol | ≤0.50% |
Metalla gravis | ≤20ppm |
Assay | 99.0% ~ 101.0% (ratione anhydrous et solvendo libera basis) |
Test Standard | Pharmacopeia Civitatum Foederatarum (USP) Standard |
Consuetudinem | API;anti-HIV |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Shanghai Ruifu Chemical Co., Ltd. est primarium fabricae et supplementi Abacavir (CAS: 136470-78-5) magna qualitate.Abacavir API carbocyclicum 2'-deoxyguanosinum nucleoside transverso transcriptase inhibitor (NRTI) et medicamentum anti-HIV ad infectio HIV tractandum adhibita est.NRTIs opus obturans HIV reverse transcriptase, HIV enzyme.Hoc productum destinatur curationi adultorum in virus immuno- ficientiae humano infectis (HIV).Tres certae partes (Abacavir, Lamivudine, et Zidovudine) pro tribus monotheragiis ad similes doses adhibentur.Abacavir, Lamivudine et Zidovudine sola commendantur per 6-8 septimanas in principio curationis.